US Merger & Acquisition SEC Filings — February 26, 2026

27-02-2026

IQM Finland Oy and Real Asset Acquisition Corp. (Nasdaq: RAAQ), a SPAC, entered a definitive business combination agreement on February 23, 2026, to take IQM public via American Depositary Shares on a leading U.S. stock exchange, with potential dual listing on Helsinki; the deal aims to fund IQM's advancement toward fault-tolerant quantum computing. IQM, a leader in full-stack superconducting quantum computers with over 300 employees and global presence, and RAAQ will host a conference call/webcast to discuss transaction highlights, with recording available at https://meetiqm.com/investors/. No financial metrics or historical performance data provided; forward-looking statements note significant risks including technical challenges, net losses, and potential redemptions.

• ·Agreement announced February 23, 2026; press release dated February 27, 2026.
• ·IQM headquartered in Finland with presence in France, Germany, Italy, Japan, Poland, Saudi Arabia, Spain, Singapore, South Korea, Taiwan, UK, US.
• ·RAAQ based in Princeton, NJ; IPO prospectus filed April 30, 2025.
• ·Upcoming SEC Form F-4 registration statement including proxy statement/prospectus.

27-02-2026

Abony Acquisition Corp. I filed an 8-K on 2026-02-27 disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details on merger or acquisition structure, parties, valuation, synergies, or impacts are provided in the filing summary. Sector is not specified, and no quantitative metrics, comparisons, or scheduled events are mentioned.

• ·AccNo: 0001213900-26-021014
• ·Filing size: 422 KB

27-02-2026

Roman DBDR Acquisition Corp. II filed an 8-K on 2026-02-27 disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger or acquisition event. The filing also includes Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). No specific deal terms, financial metrics, parties involved, or quantitative details are disclosed.

27-02-2026

Avidity Biosciences, Inc. filed an 8-K on February 27, 2026, disclosing the termination of a material definitive agreement (Item 1.02), completion of an acquisition or disposition of assets (Item 2.01), notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of the registrant (Item 5.01), departures/elections of directors/officers and compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03). These items collectively indicate a completed significant corporate transaction involving change of control and delisting, with no financial metrics, deal values, or performance comparisons provided. Item 9.01 references financial statements and exhibits, but specifics are NOT_DISCLOSED.

27-02-2026

ClearThink 1 Acquisition Corp., a blank check company targeting financial services, priced its $125M initial public offering of 12,500,000 units at $10.00 per unit, expected to list on NASDAQ under CTAAU starting February 24, 2026, with separate trading for shares (CTAA) and rights (CTAAR) thereafter. The offering, led by D. Boral Capital LLC, includes a 45-day over-allotment option for 1,875,000 additional units and is set to close on February 25, 2026, subject to customary conditions. No declines or flat metrics reported as this is an IPO pricing announcement.

• ·Registration statement effective February 13, 2026.
• ·U.S. counsel: Ruskin Moscou Faltischek, P.C.; Cayman counsel: Ogier (Cayman) LLP; Underwriters' counsel: Sichenzia Ross Ference Carmel LLP.
• ·SPAC focus: financial services sector in the United States and other developed countries.

27-02-2026

MOZAYYX Acquisition Corp., a blank check company, announced the pricing of its upsized initial public offering of 26,100,000 units at $10.00 per unit, raising $261M. Units are expected to list on the NYSE under 'MZYX.U' beginning February 25, 2026, with separate trading of Class A ordinary shares ('MZYX') and warrants ('MZYX.WS') thereafter. Cantor Fitzgerald & Co. served as sole book-running manager, with a 45-day underwriters' option for up to 3,915,000 additional units.

• ·Registration Statement on Form S-1 (333-293134) declared effective February 24, 2026.
• ·Company incorporated as exempted company under Cayman Islands laws, seeking merger or business combination.
• ·Press release dated February 24, 2026; SEC 8-K filed February 27, 2026.

27-02-2026

Miluna Acquisition Corp entered into an Indemnification Agreement with Yajuan Ding on February 25, 2026, to indemnify him against liabilities arising from his service as a director or officer, including expenses, judgments, and settlements, subject to exceptions for willful neglect, default, or fraud. The agreement provides for advancement of expenses within 30 days of request and detailed procedures for determining indemnification entitlement. No financial metrics or performance data are disclosed.

27-02-2026

VERAXA Biotech AG shareholders approved the merger with Veraxa Biotech Holding AG and an ordinary capital increase of up to CHF 223,400 at their EGM on February 27, 2026, advancing the business combination with Voyager Acquisition Corp. (NASDAQ: VACH). The approvals are prerequisites for closing, subject to Voyager shareholder approval, after which the combined entity will trade on NASDAQ under 'VRXA'. No financial performance metrics or declines were reported, highlighting progress without disclosed setbacks.

• ·Business Combination Agreement signed on April 22, 2025.
• ·Proxy statement/prospectus filed with SEC on February 19, 2026.
• ·Merger via absorption: Veraxa Biotech Holding AG acquires VERAXA and renames to Veraxa Biotech AG.

27-02-2026

TRG Latin America Acquisitions Corp., a blank check company, priced its initial public offering of 20,000,000 units at $10.00 per unit, raising $200M, with units listing on Nasdaq under 'TRGSU' starting February 26, 2026. Santander serves as sole book-running manager and has a 45-day option to purchase up to 3,000,000 additional units for over-allotments. The offering is expected to close on February 27, 2026, subject to customary conditions.

• ·Units consist of one Class A ordinary share and one right for one-tenth of a Class A ordinary share upon business combination.
• ·Class A shares and rights to trade separately under 'TRGS' and 'TRGSR' no later than 52nd day after February 25, 2026.
• ·Registration statement effective February 25, 2026.
• ·Company is Cayman Islands exempted entity targeting business combinations, focusing on Latin America expertise.